Skip to main content
. Author manuscript; available in PMC: 2024 Oct 17.
Published in final edited form as: Semin Respir Crit Care Med. 2024 Mar 14;45(3):329–341. doi: 10.1055/s-0044-1782218

Fig. 1.

Fig. 1

Our approach to initiating treatment for RA-ILD. We suggest treatment for symptomatic patients and patients with progressive RA-ILD. Risk factors for progression and UIP pattern are considered in shared decision-making regarding when to initiate treatment. HRCT, high-resolution computed tomography; ILD, interstitial lung disease; PFT, pulmonary function testing; RA, rheumatoid arthritis; UIP, usual interstitial pneumonia.